1. Home
  2. ACXP vs GCDT Comparison

ACXP vs GCDT Comparison

Compare ACXP & GCDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$1.43

Market Cap

6.2M

Sector

Health Care

ML Signal

HOLD

GCDT

Green Circle Decarbonize Technology Limited Ordinary Shares

N/A

Current Price

$0.98

Market Cap

5.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ACXP
GCDT
Founded
2017
1992
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
5.3M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
ACXP
GCDT
Price
$1.43
$0.98
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$95.50
N/A
AVG Volume (30 Days)
179.1K
252.9K
Earning Date
05-12-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$0.33
52 Week High
$8.34
$5.32

Technical Indicators

Market Signals
Indicator
ACXP
GCDT
Relative Strength Index (RSI) 47.60 78.73
Support Level $1.33 $0.55
Resistance Level $1.75 $1.19
Average True Range (ATR) 0.06 0.08
MACD 0.00 0.03
Stochastic Oscillator 37.50 100.00

Price Performance

Historical Comparison
ACXP
GCDT

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

About GCDT Green Circle Decarbonize Technology Limited Ordinary Shares

Green Circle Decarbonize Technology Ltd is a company which provides advanced energy saving solutions supported by proprietary phase change thermal energy storage materials and thermal engineering services. As an advocate of decarbonization, the Company designs, develops and provides customized energy saving solutions that bring considerable economic benefits to our clients and reduce carbon emissions for a sustainable future.

Share on Social Networks: